Skip to content
Wenlo
Sign in
← Markets

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc. (PLX) — Form 4: Insider transaction

4PLXFiled Sep 9, 2026, 1:00 PM ET· Period Sep 3, 2026

About this filing

Protalix BioTherapeutics, Inc. (PLX) filed Form 4 (insider transaction) with the SEC on Sep 9, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More PLX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.